Brute-force AI is expensive
Pushing entire patient records through large models burns compute, memory, storage, and network on data that has nothing to do with the question at hand — and the inference bill scales with data volume.
Patent pending · IN 202641072734
Illustrative engine behaviour — most milestones confirm quietly; only a deviation wakes a model, and only the cheapest sufficient one.
The problem
Pushing entire patient records through large models burns compute, memory, storage, and network on data that has nothing to do with the question at hand — and the inference bill scales with data volume.
Fixed questionnaires and generic care plans ignore what each patient actually needs right now — given their age, comorbidities, risk, and where they are on their recovery journey.
A diabetic reports chest pain; a wound patient develops neuro symptoms. Conventional pathways either ignore the signal — or re-run AI over everything, every time.
How it works
The inventive idea is simple: use a milestone-specific minimal clinical signal set as a gate on computation itself. Trajectories derive from clinical guidelines where they exist — and where they don't, an intuitive designer lets the physician define the trajectory their patients usually follow.
For every milestone of a patient's expected recovery trajectory, MedNeuron derives the handful of guideline-backed data points actually needed to confirm the patient is on track. Not the full record. Not another 40-question form. Just what matters, when it matters. And where no clear guideline exists, the physician designs the trajectory in an intuitive visual editor — encoding the course their patients actually follow — and the gate treats it exactly like a guideline-derived one.
While those signals confirm expected progress, the system suppresses AI model execution entirely and simply logs the confirmation. Only on deviation does it escalate — selecting the least costly sufficient tier, from deterministic rules to a small local model to a large model. Red-flag signals override everything for safety.
A resource-footprint ledger itemizes everything avoided — model runs, lab tests, imaging, in-person visits, patient travel — and converts computation into energy, cost, and carbon terms, down to a tokens-per-watt-per-dollar measure with auditable provenance. Efficiency isn't a claim we make; it's a number the system prints.
Patent-pending breakthroughs
Shared decision-making · natural-history reference
Alongside every treatment trajectory, MedNeuron generates a time-indexed model of the untreated course: progression stages, complications, and their likelihoods. Generated once, at zero ongoing inference cost — a static reference you can put on screen during consent. Clinical terms for the physician, plain language for the patient. Honest, not alarmist: where the natural course is benign, it says so.
Treatment-emergent sub-streams · TESS
When a symptom is explained by the active regimen — nausea on an antibiotic — MedNeuron keeps it in-stream as a lightweight sub-stream with a resolution window tied to the regimen. It escalates to a full pathway only if it persists past tolerance or crosses a severity threshold. Every branch avoided is one model call, one questionnaire, and one visit that never happened.
Efficiency as a control input · TPWD
MedNeuron converts every token used and avoided into energy and cost with auditable provenance — measured, billed, or estimated. The gate doesn't just record the metric; it acts on it, selecting the least watt-dollar model that still clears the clinical bar. Safety always overrides: a red flag forces the large model regardless of cost.
The platform
Per-milestone signal selection derived from the disease-symptom complex — the smallest progress-validating subset, with red-flag exclusions.
Deviation magnitude maps to the least-costly sufficient mode, from deterministic rules up to a large model — never more compute than required.
Collection cadence tightens on risk and loosens when milestones are met — across self-report, exam, lab, imaging, and device channels.
Unrelated signals spawn independent, cross-linked pathways with their own signal set and cadence — no contamination of the active trajectory.
Quantifies avoided model invocations, labs, imaging, visits, travel, and compute — with configurable CO₂e conversion factors.
Every suppression, escalation, and branch carries its basis: guideline source, milestone threshold, and why each signal was requested or withheld.
MedNeuron supports the treating clinician; it never diagnoses or treats on its own. Physicians review and approve every trajectory — or design their own in the trajectory editor when guidelines don't fit their patients.
Intellectual property
The minimal clinical signal set decides whether — and how much — computation runs. Claimed as a system, a method, and a medium.
Avoided model runs, orders, visits, and travel, measured against a reference pathway — the savings the system prints itself.
Expected side effects tracked inside the active trajectory, with every avoided pathway tied back to the ledger.
Provenance-tagged energy and cost profiles used by the gate to pick the cheapest clinically sufficient model.
The claims cover the mechanism, not a model. The anchor: using the clinically minimal signal set as a gate on whether and how much computation runs. Around it, the filing protects the ledger that proves the savings, the sub-stream handling of expected treatment effects, and energy/cost-aware model selection.
The specification argues a measurable technical effect — reduced processor, memory, storage, network, and model-execution load — recorded by the system's own resource-footprint ledger.
Request the investor briefBetter together
MedNeuron will ship out of the box on HealthPilot.ai — the intelligent operating system for modern healthcare, from the same company and already running in hospitals. The integration is in active development: trajectories generated at prescription, minimal signals collected through the patient portal and WhatsApp channels, and the resource ledger reported alongside billing — behind every EMR, follow-up, and patient-engagement workflow.
Running a different stack? MedNeuron is built as a control layer behind any EHR, CDS, or remote-monitoring product via a clean REST API.
Why investors should care
Continuous AI over full patient records means cost scales with data volume — and healthcare produces more data per patient every year. MedNeuron inverts the model: cost scales with deviation, and most patients, most days, are on track.
Patent-pending architecture anchored on the computation gate, with an auditable resource ledger to prove it. A control layer is not another model to commoditize.
The resource ledger reports avoided compute, avoided tests and visits, and CO₂e per patient — unit economics you can audit, not estimate.
Every health system deploying AI is about to meet its inference bill. MedNeuron is built for that moment — with distribution planned inside HealthPilot.ai.
Early access
Request early access, the investor brief, or a walkthrough with the founder. We'll come back to you personally.